inpatient / hematology and oncology

Transfusion Reactions

Last Updated: 1/5/2023

# Transfusion Reaction

Checklist
-- ABCs: 
respiratroy distress, shock, bleeding (DIC)
-- Initial Steps: stop transfusion, check blood product to ensure matches patient, alert the blood bank, send reaction panel (direct coombs, repeat type+screen and crossmatch), remaining blood product bag; do not restart transfusion until severe reaction ruled out
-- Can't Miss: AHTR, TRALI, TACO
-- Initial Treatment to Consider: tylenol, benadryl, fluids, oxygen

Assessment:
-- History: *** prior reactions, pre-medication
-- Clinical: ***resp distress, bleeding, nausea/vomiting, flushing
-- Exam: *** hypotension, fever, rash, wheezing, volume (JVP, crackles, edema)
-- Data: *** CBC, hemolysis labs, BMP, coags, UA
-- Etiology/DDx: *** acute hemolytic transfusion reaction (AHTR), febrile nonhemolytic transfusion reaction (FNHTR), anaphylaxis, minor allergic transfusion reaction, TRALI, TACO, septic transfusion

The patient's HPI is notable for ***. Exam showed ***. Labwork and data were notable for ***. Taken together, the patient's presentation is most concerning for ***, with a differential including ***.

Plan:
Workup
-- Reation panel (direct coombs, repeat type+screen and crossmatch)
-- CBC, hemolysis labs, BMP, coags, UA
-- CXR is c/f TRALI
-- NT-proBNP and POCUS if c/f overload or TACO
-- BCx if c/f sepsis

Treatment
-- Minor reactions - premedicate with tylenol and benadryl, run at slower rate
-- Serious reactions - reaction workup; IVF, pressors

Get Template PDF

PDF coming soon!

If You Remember Nothing Else

Be judicious with who you choose to transfuse. Severe transfusion reactions are rare but life-threatening. Severe reactions can initially present like mild reactions (fevers, local rash/itching); the first time a patient has symptoms the transfusion should be stopped and a workup should be sent to rule out severe reaction before re-transfusion. Patients with mild symptoms can be premedicated with tylenol and benadryl.

Clinical Pearls

  • We do not transfuse whole blood, but rather components of blood including packed red cells, platelets, plasma (clotting factors), and cryoprecipitate (fibrinogen)
  • After blood is collected, it is centrifuged in sequence with removal of different components at each step - this leads to packed reds with leftover WBCs that are leukodepleted and/or irradiated, platelets that have some donor antibodies in them, and plasma that has clotting factors and fibrinogen; cyroprecipitate is a smaller volume that just has the fibrinogen and is useful in DIC
  • 1 unit of pRBCs raises Hgb by 1; 1 unit platelets raises Plt by ~20-50; plasma response is variable, and 2 units are often given to assess for response in INR; cryoprecipitate is also variable
  • Platelets historically have been given as 6 "units" per "dose" when the platelets were taken from whole blood; when taken from pheresis the blood bank creates 1 "dose" that is equivalent to the historical 6 units; make sure you know how much you are ordering
  • Massive Transfusion involves giving 1:1:1 RBCs, platelets, and plasma - the goal is to avoid coagulopathy through dilution, but need to also be on the lookout for hypocalcemia (from citrate), hyperkalemia (from lysis), hypothermia (from cooled product)
  • Type and Screen - typing is checking for ABO "type"; screening is looking for antigens on the donor RBCs that the host may have abs against; crossmatch is either done electronically if the screen is negative, or manually searching for compatable blood if the screen is positive
  • T+S needs to be sent every 3 days because the reactivity of the abs present in the blood sample may not be as robust after sitting for a period of time, and this ensures that something isn't missed; also if patients receive product it is possible during the course of the admission that they will develop antibodies against donor antigens that would only be seen on a repeat sample
  • Acute Hemolytic transfusion reaction (AHTR) is caused by ABO incompatability - donor RBCs are destoyed by host abs or donor abs destroy the host RBCs via complement activation which leads to hemolysis and possibly DIC; Febrile nonhemolytic transfusion reaction (FNHTR) is flu-like symptoms caused by cytokines from donor WBCs; Anaphylaxis is a type I reaction to donor plasma proteins (often in IgA deficiency); TRALI is lung injury due to HLA abs that activate WBCs in the host which release cytokines leading to inflammation and edema in the lungs (ARDS); Transfusion Associated Circulatory Overload (TACO) is not a reaction, and is instead simply fluid overload from the volume of product given

Trials and Literature

Other Resources